NHS Trust Sponsor Research Into Inherited Heart Conditions
A leading University NHS Foundation Trust, based in the UK, is the study sponsor for a multi-site randomized 1-year evaluation of a pharmaceutical treatment for patients with cardiomyopathy.
Enabling Global AI Software Provider To Expand Their Business Into Healthcare Services
A specialist healthtech company headquartered in Ukraine, who successfully developed a leading, cloud-based AI analysis platform, sought to expand their business model. Their goal was to create an end-to-end remote holter monitoring service for hospitals and clinics by incorporating clinical-grade wireless ECG devices.
Caring For COVID-19 Patients
A leading hospital group, based in Chennai, India approached LifeSignals in 2020 to introduce a wireless vital sign monitoring system for COVID-19 patients in numerous locations to help respond to the pandemic and save lives.
Remote Physician & Nursing Oversight in Step-Down Facilities and At-Home
A health monitoring center based in New York, USA for at-home physicians and nursing oversight companies has been working with LifeSignals since 2018 to broaden their services to skilled nursing facilities.
Extended Holter Monitoring Delivered To Vulnerable Patients In Their Own Homes
In 2016, LifeSignals partnered with a company based in Kerala, India that is transforming the way ambulatory cardiac monitoring is delivered and become the new normal among the leading cardiologists and neurologists in hospitals across the country.
Expanding Connected Cardiac Care in India
An ambitious AI healthcare technology company based in Hyderabad, India approached LifeSignals in 2019 to take healthcare closer to consumers by utilizing the power of cloud technology.
Enabling Remote Cardiac Monitoring Across The Remote Islands Of The Philippines
A telehealth and cardiac screening company headquartered in Manila has been working with LifeSignals as of early 2020 to expand remote cardiac monitoring in the Philippines.
Bringing Reliable Mobile Cardiac Telemetry To More Patients in the United States
A leading Independent Diagnostic Testing Facility (IDTF), providing ambulatory cardiac monitoring services headquartered in New York, USA, came to LifeSignals in 2019 in search of a reliable, affordable, and FDA approved wireless biosensor that accurately captured and transmitted multi-channel ECG, for a real-time MCT application.
LifeSignals Receives FDA 510 (k) Approval for LifeSignals LX1550 Multi-parameter Remote Monitoring Platform
Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.
LifeSignals LX1550 Platform Receives CE Mark
LifeSignals receives CE Mark Approval for LifeSignals LX1550E Multiparameter Remote Monitoring Platform. Enables healthtech partners to deliver continuous remote patient vital signs monitoring within hospital and home settings.
